tagtociclib   Click here for help

GtoPdb Ligand ID: 11525

Synonyms: compound 19 [PMID: 35485642] | example 13 [WO2020157652] | PF-07104091 | PF07104091
Compound class: Synthetic organic
Comment: PF-07104091 is a novel, selective CDK2 inhibitor [2]. It is identical to the chemical structure for example 13 that is claimed in patent WO2020157652 [1], and it matches the structure for the INN tagtociclib (proposed INN list 129, August 2023).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 3
Rotatable bonds 10
Topological polar surface area 123.16
Molecular weight 404.22
XLogP 1.73
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES COCc1nn(c(c1)C(=O)Nc1n[nH]c(c1)[C@H]1CC[C@H](C1)OC(=O)NC(C)C)C
Isomeric SMILES COCc1nn(c(c1)C(=O)Nc1n[nH]c(c1)[C@H]1CC[C@H](C1)OC(=O)NC(C)C)C
InChI InChI=1S/C19H28N6O4/c1-11(2)20-19(27)29-14-6-5-12(7-14)15-9-17(23-22-15)21-18(26)16-8-13(10-28-4)24-25(16)3/h8-9,11-12,14H,5-7,10H2,1-4H3,(H,20,27)(H2,21,22,23,26)/t12-,14+/m0/s1
Bioactivity Comments
PF-07104091 has 100-fold selectivity against CDK1, 200 to 400-fold selectivity against CDK4 and CDK6, 170-fold selectivity against CDK9, and greater than 500-fold selectivity against GSK3β.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
cyclin dependent kinase 2 Hs Inhibitor Inhibition 8.9 pIC50 - 2
pIC50 8.9 (IC50 1.16x10-9 M) [2]
Description: Inhibition of CDK2/Cyclin E